FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387026008: Dichloralphenazone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461204014 Dichloralphenazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481140011 Dichloralphenazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2553328012 Dichlorphenazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2553330014 Dichloralantipyrine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
192641000077119 dichloralphénazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dichloralphenazone (substance) Is a Sedative/neuroleptic false Inferred relationship Some
Dichloralphenazone (substance) Is a Pyrazole derivative true Inferred relationship Some
Dichloralphenazone (substance) Is a Sedative (substance) false Inferred relationship Some
Dichloralphenazone (substance) Is a Chloral sedative agent false Inferred relationship Some
Dichloralphenazone (substance) Is a Hypnotic agent (substance) true Inferred relationship Some
Dichloralphenazone (substance) Is a Chloral derivative (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing dichloralphenazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dichloralphenazone (substance) Inferred relationship Some 1
Dichloralphenazone poisoning Causative agent (attribute) True Dichloralphenazone (substance) Inferred relationship Some 1
Accidental dichloralphenazone poisoning (disorder) Causative agent (attribute) False Dichloralphenazone (substance) Inferred relationship Some
Intentional dichloralphenazone poisoning Causative agent (attribute) False Dichloralphenazone (substance) Inferred relationship Some
Dichloralphenazone poisoning of undetermined intent Causative agent (attribute) False Dichloralphenazone (substance) Inferred relationship Some 1
Dichloralphenazone adverse reaction Causative agent (attribute) True Dichloralphenazone (substance) Inferred relationship Some 1
Allergy to dichloralphenazone Causative agent (attribute) False Dichloralphenazone (substance) Inferred relationship Some
Dichloralphenazone overdose Causative agent (attribute) True Dichloralphenazone (substance) Inferred relationship Some 1
Accidental dichloralphenazone overdose Causative agent (attribute) True Dichloralphenazone (substance) Inferred relationship Some 1
Intentional dichloralphenazone overdose Causative agent (attribute) True Dichloralphenazone (substance) Inferred relationship Some 1
Dichloralphenazone overdose of undetermined intent Causative agent (attribute) False Dichloralphenazone (substance) Inferred relationship Some 1
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dichloralphenazone (substance) Inferred relationship Some
Product containing dichloralphenazone and isometheptene and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dichloralphenazone (substance) Inferred relationship Some 1
Acetaminophen + dichloralantipyrine + isometheptene mucate (1:1) 325mg/100mg/65mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dichloralphenazone (substance) Inferred relationship Some
Acetaminophen + dichloralantipyrine + isometheptene mucate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dichloralphenazone (substance) Inferred relationship Some
Accidental dichloralphenazone poisoning (disorder) Causative agent (attribute) True Dichloralphenazone (substance) Inferred relationship Some 1
Intentional dichloralphenazone poisoning Causative agent (attribute) True Dichloralphenazone (substance) Inferred relationship Some 1
Allergy to dichloralphenazone Causative agent (attribute) True Dichloralphenazone (substance) Inferred relationship Some 1
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Dichloralphenazone (substance) Inferred relationship Some 3
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dichloralphenazone (substance) Inferred relationship Some 2
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Dichloralphenazone (substance) Inferred relationship Some 2
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Dichloralphenazone (substance) Inferred relationship Some 3
Product containing dichloralphenazone and isometheptene and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dichloralphenazone (substance) Inferred relationship Some 1
Product containing only dichloralphenazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dichloralphenazone (substance) Inferred relationship Some 1
Product containing only dichloralphenazone and isometheptene and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dichloralphenazone (substance) Inferred relationship Some 1
Dichloralphenazone and isometheptene and paracetamol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dichloralphenazone (substance) Inferred relationship Some 1
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dichloralphenazone (substance) Inferred relationship Some 1
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dichloralphenazone (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start